SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8
BNT162 Vaccine
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
/ immunology
COVID-19
/ prevention & control
COVID-19 Vaccines
/ immunology
Granzymes
HIV Infections
/ immunology
HIV-1
Humans
RNA, Messenger
/ genetics
SARS-CoV-2
Vaccination
Vaccines, Synthetic
Virus Latency
mRNA Vaccines
nef Gene Products, Human Immunodeficiency Virus
/ genetics
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
19 08 2022
19 08 2022
Historique:
received:
06
06
2022
accepted:
26
07
2022
entrez:
19
8
2022
pubmed:
20
8
2022
medline:
24
8
2022
Statut:
epublish
Résumé
Efforts to cure HIV have focused on reactivating latent proviruses to enable elimination by CD8
Identifiants
pubmed: 35985993
doi: 10.1038/s41467-022-32376-z
pii: 10.1038/s41467-022-32376-z
pmc: PMC9389512
doi:
Substances chimiques
COVID-19 Vaccines
0
RNA, Messenger
0
Vaccines, Synthetic
0
mRNA Vaccines
0
nef Gene Products, Human Immunodeficiency Virus
0
nef protein, Human immunodeficiency virus 1
0
nef protein, Human immunodeficiency virus 2
0
Granzymes
EC 3.4.21.-
BNT162 Vaccine
N38TVC63NU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
4888Subventions
Organisme : NIAID NIH HHS
ID : UM1 AI164565
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI162221
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI170245
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002384
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI150398
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI126617
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI131798
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
N Engl J Med. 1996 May 9;334(19):1222-30
pubmed: 8606717
J Clin Microbiol. 2014 Nov;52(11):3944-51
pubmed: 25187636
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
AIDS Res Hum Retroviruses. 1997 Apr 10;13(6):473-80
pubmed: 9100988
Science. 1997 Nov 14;278(5341):1295-300
pubmed: 9360927
J Clin Invest. 2018 Feb 1;128(2):876-889
pubmed: 29355843
Nat Med. 2020 Sep;26(9):1339-1350
pubmed: 32895573
PLoS Pathog. 2014 Aug 14;10(8):e1004287
pubmed: 25122219
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nat Commun. 2021 Jan 8;12(1):165
pubmed: 33420062
Science. 1997 Nov 14;278(5341):1291-5
pubmed: 9360926
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13193-7
pubmed: 9371822
Autophagy. 2021 Nov;17(11):3408-3423
pubmed: 33459125
Immunity. 2012 Mar 23;36(3):491-501
pubmed: 22406268
J Exp Med. 2017 Apr 3;214(4):959-972
pubmed: 28341641
Lancet HIV. 2014 Oct;1(1):e13-21
pubmed: 26423811
Adv Drug Deliv Rev. 2021 Sep;176:113900
pubmed: 34324884
AIDS. 2016 Sep 24;30(15):2289-98
pubmed: 27427877
Genome Biol. 2014;15(12):550
pubmed: 25516281
JCI Insight. 2021 Feb 8;6(3):
pubmed: 33400687
NPJ Vaccines. 2022 Feb 28;7(1):28
pubmed: 35228535
J Infect Dis. 2000 Feb;181(2):522-31
pubmed: 10669335
Nature. 2020 Feb;578(7793):154-159
pubmed: 31969705
J Exp Med. 2004 Apr 5;199(7):925-36
pubmed: 15051762
Vaccine. 2009 Apr 21;27(18):2418-25
pubmed: 19368783
Nature. 1998 Jan 22;391(6665):397-401
pubmed: 9450757
Nature. 2021 Aug;596(7872):410-416
pubmed: 34252919
J Exp Med. 1998 Dec 21;188(12):2199-204
pubmed: 9858506
PLoS Pathog. 2015 Sep 17;11(9):e1005142
pubmed: 26379282
Front Immunol. 2021 Aug 05;12:715644
pubmed: 34421920
PLoS Pathog. 2016 Apr 15;12(4):e1005545
pubmed: 27082643
Nature. 2012 Jul 25;487(7408):439-40
pubmed: 22836995
Immunity. 2003 Mar;18(3):355-65
pubmed: 12648453
Autophagy. 2019 Apr;15(4):744-746
pubmed: 30653393
Vaccines (Basel). 2021 Feb 07;9(2):
pubmed: 33562203
Annu Rev Immunol. 2008;26:389-420
pubmed: 18304003
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Cell Rep. 2021 Aug 31;36(9):109643
pubmed: 34469719
EBioMedicine. 2015 Jun 27;2(8):874-83
pubmed: 26425694
J Exp Med. 2007 Apr 16;204(4):941-9
pubmed: 17420267
J Immunol. 2005 Mar 15;174(6):3757-64
pubmed: 15749916
Nature. 2020 Feb;578(7793):160-165
pubmed: 31969707
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Clin Invest. 2022 Apr 1;132(7):
pubmed: 35133986
Lancet. 2020 Mar 14;395(10227):888-898
pubmed: 32085823
PLoS Pathog. 2020 Oct 19;16(10):e1008906
pubmed: 33075109
Cell. 2013 Oct 24;155(3):540-51
pubmed: 24243014
JCI Insight. 2018 Oct 4;3(19):
pubmed: 30282829
J Virol. 2021 Jul 12;95(15):e0242520
pubmed: 33980597
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
AIDS. 1998 Oct 1;12(14):F145-50
pubmed: 9792370
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Virol. 1994 Apr;68(4):2726-30
pubmed: 7511177
Cell. 2022 Jan 20;185(2):266-282.e15
pubmed: 35026153
Cell Immunol. 2007 May;247(1):36-48
pubmed: 17825804
BMC Infect Dis. 2017 Aug 29;17(1):595
pubmed: 28851294
J Virol. 2021 Jan 27;:
pubmed: 33504598
Nature. 2019 Feb;566(7742):120-125
pubmed: 30700913
Nature. 2020 Sep;585(7824):261-267
pubmed: 32848246
Retrovirology. 2013 Oct 24;10:119
pubmed: 24156240
PLoS One. 2011 Jan 17;6(1):e16241
pubmed: 21264227
Science. 2020 Sep 4;369(6508):1210-1220
pubmed: 32788292
AIDS Res Hum Retroviruses. 2012 Dec;28(12):1687-92
pubmed: 22734882
Immunity. 2020 Jun 16;52(6):971-977.e3
pubmed: 32413330
J Virol. 2022 Mar 9;96(5):e0173021
pubmed: 35019724
J Clin Invest. 2015 May;125(5):1901-12
pubmed: 25822022
PLoS Pathog. 2017 Sep 20;13(9):e1006629
pubmed: 28931091
J Virol. 2020 Apr 16;94(9):
pubmed: 32051267
Nat Rev Immunol. 2020 Sep;20(9):537-551
pubmed: 32203325
J Clin Invest. 2020 May 1;130(5):2542-2559
pubmed: 32027622